Similar Items: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
- Research Progress on the Molecular Mechanism of Metformin Regulating AMPK Signaling Pathway in Inhibiting Liver Cancer
- Scientometric Analysis of the Combined Application of Molecular Docking Technique and CRISPR Genome Editing Technology
- Scientometric Analysis of the Combined Application of Molecular Docking Technique and CRISPR Genome Editing Technology
- Scientometric Analysis of the Combined Application of Molecular Docking Technique and CRISPR Genome Editing Technology
- Identifying high-risk combinations of metformin during COVID-19
- Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing [Corrigendum]